December 12, 2019
Dear Valued Customer,
We are excited to announce the merger of New England Peptide and Peptides International. This partnership will vastly expand the products and services that our customers have come to expect and deserve. With a focus on high quality, rapid delivery, and customer needs, New England Peptide and Peptides International will work hard to become your one stop shop for all of your research-grade peptide and antibody needs, predominantly used in drug discovery endeavors.
Located in a suburb of Boston, Massachusetts, New England Peptide has long been the choice of customers for custom peptides for screening libraries, mass spectrometry standards, and custom polyclonal and monoclonal antibodies. New England Peptide will bring their years of expertise in small to mid-scale peptide synthesis throughput production and years of in-house experience with specialized antigen design, antibody purification, and custom antibody conjugation methods. New England Peptide is committed to delivering high quality peptides and antibodies to a wider market around the globe.
Located in Louisville, Kentucky, Peptides International is a global leader in catalog and custom peptide production. Areas include, but are not limited to: multiple disulfide bonded peptides and toxins, RGD peptides, GLP-1 receptor agonists, hepcidins, peptide macrocycles, enzyme inhibitors and substrates. Peptides International is specialized in addressing the most complex peptide projects and offers customers full chemical optimization and scale-up services (up to 1kg for some products). Peptides International, certified to ISO 9001:2015, will continue to focus on high quality products and services.
For our customers it will be business as usual. All orders and projects will be delivered as promised. Your contacts and interactions will remain the same and your business and orders remain our top priority. The synergy between New England Peptide and Peptides International will function to complement each other and the strengths of each will be utilized to better serve you.
We will keep you informed as our products and services expand, in these exciting times, and are always available to address any questions or concerns you may have. We look forward to your continued business.
New England Peptide
José de Chastonay
Chairman of the Board
Jacqulyn B. Spatola
Here is the link to the press release: https://www.prnewswire.com/news-releases/ampersand-capital-partners-acquires-peptides-international-and-merges-company-with-new-england-peptide-300974990.html